Insider Transactions in Q4 2021 at Theravance Biopharma, Inc. (TBPH)
Insider Transaction List (Q4 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 14
2021
|
Rhonda Farnum SVP, COMM & MEDICAL AFFAIRS |
BUY
Grant, award, or other acquisition
|
Direct |
27,500
+7.33%
|
-
|
|
Dec 02
2021
|
Richard A Graham SVP, RESEARCH & DEVELOPMENT |
BUY
Grant, award, or other acquisition
|
Direct |
240,000
+36.98%
|
-
|
|
Dec 02
2021
|
Andrew A. Hindman SVP, CHIEF FINANCIAL OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
340,000
+40.13%
|
-
|
|
Nov 19
2021
|
Rick E Winningham CHIEF EXECUTIVE OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
11,404
-0.87%
|
$91,232
$8.36 P/Share
|
|
Nov 19
2021
|
Vijay Sabesan SVP, TECHNICAL OPERATIONS |
SELL
Payment of exercise price or tax liability
|
Direct |
5,191
-2.16%
|
$41,528
$8.36 P/Share
|
|
Nov 19
2021
|
Philip D Worboys SVP, RESEARCH & TRANSL SCIENCE |
SELL
Payment of exercise price or tax liability
|
Direct |
4,310
-1.29%
|
$34,480
$8.36 P/Share
|
|
Nov 19
2021
|
Andrew A. Hindman SVP, CHIEF FINANCIAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
1,350
-0.8%
|
$10,800
$8.36 P/Share
|
|
Nov 19
2021
|
Richard A Graham SVP, RESEARCH & DEVELOPMENT |
SELL
Payment of exercise price or tax liability
|
Direct |
4,263
-2.46%
|
$34,104
$8.36 P/Share
|
|
Nov 19
2021
|
Kenneth R Pitzer SVP, PROD STRAT & COMM PLNG |
SELL
Payment of exercise price or tax liability
|
Direct |
4,310
-1.2%
|
$34,480
$8.36 P/Share
|
|
Nov 19
2021
|
Frank Pasqualone SVP, CHIEF BUSINESS OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
3,779
-0.87%
|
$30,232
$8.36 P/Share
|
|
Nov 19
2021
|
Ann Brady PRESIDENT, TBIL |
SELL
Payment of exercise price or tax liability
|
Direct |
3,169
-2.6%
|
$25,352
$8.36 P/Share
|